Alzheimers Flashcards
(9 cards)
1
Q
what is dementia
A
a collection of symptoms caused by brain disorders that affect thinking. behaviour and ability to perform daily tasks
2
Q
some symptoms of dementia
A
- memory loss
- language difficulty
- disorientation of time and place
- forgetting daily tasks
- misplacing items
- changes in personality
- changes in mood
- loss of intiative
- poor judgement
- problems with abstract thinking
3
Q
what/describe 2 forms of alzheimers
A
Sporadic
- no family link
- most common
- complex combo of genes, env, and lifestyle
- age is greatest factor
Familial
- genetic link, ,runs in the family
- very rare, less than 5%
4
Q
what parts of the brain are affected by AD?
A
Entorhinal Cortex - area of the brain that is a hub for a network for memory, nagivation, time perception - located in the medial temporal lobe, lateral to the hippocampus - sends input to hippocampus Cerebral Cortex - fn is language and info processing - begins to shrink Hippocampus - fn is for new memory formation - begins to shrink Vesicles - contains CSF and grows larger
5
Q
Describe the 2 major characteristics of AD
A
- Senile Plaques/ Neuritic Plaques
- extercellular accumulation of insoluble fragments of amyloid-beta
- AB 42 most seen in AD - NFTs
- intracellular accumlation of hypoerphosrylated tau strands
6
Q
what is the amyloid cascade hypothesis
A
the overproduciton of AB causes cell loss, NFTs, leading to dementia
7
Q
what is tau
A
- a heat stable protein for MT that allows MT assembly and organization
- 4 major components: N terminal, C terminal, MBD, and proline-rich domain
- has multiple binding sites which allow for many interactions with cell signalling
8
Q
what is the “sequence” that leads to NFTs?
A
Hyperphosphorylated tau -> Paired Helical Filaments -> Neurofirially Tau Tangles
9
Q
what are 3 main things biomarkers should do?
A
- ability to diagnose AD with specificty and high sensitivity
- ability to recognize intial stage of disease and montor progress of disease
- be able to track the effectiveness of the therapeutic drugs